Synthetic Biologics, Inc. (SYN)
R&D Expense Growth
257.18%
Quarterly · Period ending:
SYN R&D Expense Growth
Latest reported257.18%period ending
Latest reported257.18%period ending
SYN Quarterly R&D Growth (QoQ) (0.00% → 257.18%)
Latest values, visible window
High-resolution chart · PNG
SYN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 14.2857% | |
| 75% | |
| 100% | |
| 0% | |
| -87.5% | |
| 220% | |
| -16.6667% | |
| -75% | |
| 26.3158% | |
| 0% | |
| 0% | |
| -100% | |
| -30.7692% | |
| -43.4783% | |
| 76.9231% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 833.3333% | |
| -88.4615% | |
| -54.386% | |
| 0% |